Hikma Pharmaceuticals en las noticias
Medicamentos accesibles de alta calidad
Tamtam encontró 13 artículos recientes sobre Hikma Pharmaceuticals.
- Hikma stock heads into the open after a modest gain
- What Does Hikma Pharmaceuticals' (LSE:HIK) Dividend Mean For UK Holders?
- Hikma Pharmaceuticals climbs Friday, outperforms market
- A needle-free epinephrine spray is under review in the US, Europe and UK
- Hikma advances its epinephrine nasal spray with multi-market regulatory filings
- Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets
- ii view: Hikma keeps a healthy pulse with solid first half
- Hikma Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data
- Hikma Pharmaceuticals rallies on improving trends
- Rep. Cockley Applauds Hikma Pharmaceuticals Expansion, Investment in Columbus Workforce | Republican News
- Skinny labelling after Hikma v Amarin: active inducement in the US Supreme Court (via Passle)
- Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million
- Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing their products
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Hikma Pharmaceuticals?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares